BioLeap LLC hopes to be part of the solution to Big Pharma's pipeline problem. Its computational technology for identifying and optimizing lead compounds focuses on the free energy of binding, which represents an enormous computational problem. But the developers of BioLeap's technology have created an industrial process that makes such calculations feasible in a reasonably fast time frame.
346A Lurgan Road
New Hope, PA 18938
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
